The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant

被引:19
作者
Aerts, J. G. J. V.
Delahaye, M.
Van der Kwast, T. H.
Davidson, B.
Hoogsteden, H. C.
Van Meerbeeck, J. R.
机构
[1] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands
[2] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
[3] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[4] Mt Sinai Hosp, Toronto, ON, Canada
[5] Ghent Univ Hosp, Dept Pulm Dis, Ghent, Belgium
关键词
mesothelioma; cytology; pleural effusion; immunocytochemistry;
D O I
10.1002/dc.20486
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The aim of the study was to establish in a prospective and blinded manner the diagnostic yield of morphology, immunocytochemistry (ICH) and electron microscopy (EM) in the cytological analysis of malignant pleural mesothelioma (MPM). Pleural fluid from consecutive patients, 14 with a histologically proven MPM, 12 with a malignant pleuritis due to adenocarcinoma (AC), and 13 with a reactive pleural effusion (RM),,was separately analyzed. Smears were incubated with monoclonal antibodies (Tag72, Ber-Ep4, anti-CEA, EMA). These were considered suggestive for MPM when only EMA stained positive, for AC when three out of four markers stained positive, and for RM when no marker stained positive. The post-test probability of the morphological, ICH, and EM analysis were 92, 100, 92% or MPM, 91, 100, 86% for AC, and 88, 88, 90% for RM, respectively. We concluded that the high post-test probability of a combined morphological and ICH diagnosis of MPM warrants to cease further diagnostic procedures in these patients. Electron microscopy did not add to accuracy of diagnosis.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 32 条
[1]   An optimized battery of eight antibodies that can distinguish mast gases at epithelial mesothelioma from adenocarcinoma [J].
Brockstedt, U ;
Gulyas, M ;
Dobra, K ;
Dejmek, A ;
Hjerpe, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) :203-209
[2]  
Chhieng DC, 2000, CANCER CYTOPATHOL, V90, P194, DOI 10.1002/1097-0142(20000625)90:3<194::AID-CNCR8>3.0.CO
[3]  
2-K
[4]  
Churg A, 2000, AM J SURG PATHOL, V24, P1183
[5]  
Cury PM, 1999, J PATHOL, V189, P251, DOI 10.1002/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO
[6]  
2-F
[7]   The role of desmin and N-cadherin in effusion cytology - A comparative study using established markers of mesothelial and epithelial cells [J].
Davidson, B ;
Nielsen, S ;
Christensen, J ;
Asschenfeldt, P ;
Berner, A ;
Risberg, B ;
Johansen, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1405-1412
[8]   IMMUNOCYTOCHEMISTRY OF MALIGNANT MESOTHELIOMA - OV632 AS A MARKER OF MALIGNANT MESOTHELIOMA [J].
DELAHAYE, M ;
HOOGSTEDEN, HC ;
VANDERKWAST, TH .
JOURNAL OF PATHOLOGY, 1991, 165 (02) :137-143
[9]  
Delahaye M, 1997, DIAGN CYTOPATHOL, V17, P115, DOI 10.1002/(SICI)1097-0339(199708)17:2<115::AID-DC6>3.3.CO
[10]  
2-4